Clinical Trial Update: Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP). [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating indocyanine green–mediated photothrombosis for neovascular age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Opto Eletronica S.A. | Conditions: Maculopathy, Age-Related | Phase 2 | Status: UNKNOWN